CN Patent

CN103596943B — 用作kv3抑制剂的乙内酰脲衍生物

Assigned to Autifony Therapeutics Ltd · Expires 2016-10-12 · 10y expired

What this patent protects

本发明提供了式(I)的化合物： 所述化合物是Kv3通道的抑制剂，用于预防或治疗相关障碍。

USPTO Abstract

本发明提供了式(I)的化合物： 所述化合物是Kv3通道的抑制剂，用于预防或治疗相关障碍。

Drugs covered by this patent

Patent Metadata

Patent number
CN103596943B
Jurisdiction
CN
Classification
—
Expires
2016-10-12
Drug substance claim
No
Drug product claim
No
Assignee
Autifony Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.